Assessment of neuropsychomotor development through the application of the Denver II scale in children monitored at a high-risk outpatient clinic

OBJECTIVES: the study aims to evaluate the neuropsychomotor development of newborns and infants treated at an outpatient clinic, using the Denver II Developmental Screening Test. METHODS: this is a cross-sectional, prospective study, carried out through the analysis of medical records and an electronic database, in which 100 patients, being followed up at a risk outpatient clinic in a tertiary hospital, underwent the Developmental Screening Test Denver II Revised ages zero to 6 years old will be assessed. The variables considered for the study will be: gestational age, birth weight, Apgar score, complications and diagnoses in the neonatal period. RESULTS: the sample showed that 70 (89.7%) of the participants had a satisfactory result for the Denver test, 5 (6.4%) were classified as doubtful and 3 (3.8%) as problematic. That is, most infants were considered as children who did not present delays. While 100% of the problematic ones had a neurological pathology, this percentage was only 40% among the doubtful ones and 31.4% among those who had a satisfactory result for the Denver test. CONCLUSION: it was observed that there was a high number of children with satisfactory results for the Denver test, concluding that they had good indicators in the first years of life. This condition may be related to the follow-up that children and mothers receive through pediatric outpatient care specializing in preterm infants, since the main objective is to track risks and minimize the negative impact that factors may have on development.